Fibrin network architectures in pure platelet-rich plasma as characterized by fiber radius and correlated with clotting timePEREZ, Amanda G. M; RODRIGUES, Ana A; LUZO, Angela C. M et al.Journal of materials science. Materials in medicine. 2014, Vol 25, Num 8, pp 1967-1977, issn 0957-4530, 11 p.Article

The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover studySHIN, J. S; LEE, J. Y; CHO, K. H et al.Alimentary pharmacology & therapeutics. 2014, Vol 40, Num 5, pp 548-561, issn 0269-2813, 14 p.Article

Patients' perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapyGEBLER-HUGHES, Elizabeth S; KEMP, Linda; BOND, Malcolm J et al.Therapeutic advances in drug safety (Print). 2014, Vol 5, Num 6, pp 220-228, issn 2042-0986, 9 p.Article

Probable Interaction Between an Oral Vitamin K Antagonist and Turmeric (Curcuma longa)DAVELUY, Amélie; GENIAUX, Hélène; THIBAUD, Lucile et al.Thérapie (Paris). 2014, Vol 69, Num 6, pp 519-520, issn 0040-5957, 2 p.Article

Comparison of pharmacokinetics between sarpogrelate hydrochloride immediate-release formulation and controlled-release formulationKIM, Tae-Eun; KIM, Jung-Ryul; JIN AH JUNG et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 2, pp 114-119, issn 0946-1965, 6 p.Article

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, CanadaTETT, Susan E; SKETRIS, Ingrid; COOKE, Charmaine et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 7, pp 735-743, issn 1053-8569, 9 p.Article

Mastocytosis: update on pharmacotherapy and future directionsCARLOS CARDET, Juan; AKIN, Cem; MIN JUNG LEE et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 15, pp 2033-2045, issn 1465-6566, 13 p.Article

New Perspectives in Antiplatelet TherapyTELLO-MONTOLIU, A; JOVER, E; RIVERA, J et al.Current medicinal chemistry. 2012, Vol 19, Num 3, pp 406-427, issn 0929-8673, 22 p.Article

Folding Versus Charge: Understanding Selective Target Recognition by the Thrombin AptamersMARSON, Giuseppe; PALUMBO, Manlio; SISSI, Claudia et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 14, pp 2027-2035, issn 1381-6128, 9 p.Article

Thrombin Binding Aptamer, More than a Simple Aptamer: Chemically Modified Derivatives and Biomedical ApplicationsAVINO, Anna; FABREGA, Carme; TINTORE, Maria et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 14, pp 2036-2047, issn 1381-6128, 12 p.Article

History of HeparinBARROWCLIFFE, T. W.Handbook of experimental pharmacology. 2012, Vol 207, pp 3-22, issn 0171-2004, 20 p.Article

Low-Molecular-Weight Heparins: Differential Characterization/Physical CharacterizationGUERRINI, Marco; BISIO, Antonella.Handbook of experimental pharmacology. 2012, Vol 207, pp 127-157, issn 0171-2004, 31 p.Article

Non-anticoagulant Effects of Heparin: An OverviewLEVER, Rebecca; PAGE, Clive P.Handbook of experimental pharmacology. 2012, Vol 207, pp 281-305, issn 0171-2004, 25 p.Article

Glycosaminoglycan and Chemokine/Growth Factor InteractionsSHUTE, Janis.Handbook of experimental pharmacology. 2012, Vol 207, pp 307-324, issn 0171-2004, 18 p.Article

Small RNAs as Potential Platelet TherapeuticsEDELSTEIN, Leonard C; BRAY, Paul F.Handbook of experimental pharmacology. 2012, Vol 210, pp 435-445, issn 0171-2004, 11 p.Article

Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitorsYOSHIKAWA, Kenji; YOSHINO, Toshiharu; TAKEMURA, Makoto et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 7, pp 2133-2140, issn 0960-894X, 8 p.Article

Evaluation of Anticoagulation Management and Chronic Disease State Control in a Pharmacist-Run Pharmacotherapy/ Anticoagulation ClinicSEASE, Julie M; BLAKE, Elizabeth W; GOWAN, Mollie et al.The Journal of pharmacy technology. 2011, Vol 27, Num 1, pp 3-8, issn 8755-1225, 6 p.Article

Fibrin Sealant (Evicel [Quixil/Crosseal™]): A Review of its Use as Supportive Treatment for Haemostasis in SurgeryDHILLON, Sohita.Drugs (Basel). 2011, Vol 71, Num 14, pp 1893-1915, issn 0012-6667, 23 p.Article

Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 AntagonistGHOSAL, Anima; XIAOWEN LU; PENNER, Natalia et al.Drug metabolism and disposition. 2011, Vol 39, Num 1, pp 30-38, issn 0090-9556, 9 p.Article

Sortie de réserve hospitalière : Ferinject^® = End of hospital restriction: Ferinject^®REY, Jean-Baptiste.Journal de pharmacie clinique (Paris). 2011, Vol 30, Num 4, pp 257-258, issn 0291-1981, 2 p.Article

Discovery of inhibitors of plasminogen activator inhibitor-1: Structure-activity study of 5-nitro-2-phenoxybenzoic acid derivativesPANDY, Vrajesh; JAIN, Mukul; RAVIYA, Mehul et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 19, pp 5701-5706, issn 0960-894X, 6 p.Article

Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteasesSILES, Rogelio; KAWASAKI, Yuko; ROSS, Patrick et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 18, pp 5305-5309, issn 0960-894X, 5 p.Article

Synthesis of a stable-isotope-labeled biotinylated pentasaccharide conjugate (EP217609), a dual-effect anticoagulant drugRICHARD, Sébastien; AHMED EL HADRI; SCHREUDER GOEDHEIJT, Marcel et al.Journal of labelled compounds & radiopharmaceuticals. 2011, Vol 54, Num 9-10, pp 637-644, issn 0362-4803, 8 p.Article

The successful quest for oral factor Xa inhibitors; learnings for all of medicinal chemistry?YOUNG, Robert J.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6228-6235, issn 0960-894X, 8 p.Article

A tissue adhesives evaluated in vitro and in vivo analysisXIUMEI MO; IWATA, Hiroo; IKADA, Yoshito et al.Journal of biomedical materials research. Part A. 2010, Vol 94, Num 1, pp 326-332, issn 1549-3296, 7 p.Article